184 related articles for article (PubMed ID: 6416260)
1. [Beta-propiolactone as a sterilizing agent in the manufacture of intravenous immunoglobulin preparations].
Stephan W; Dichtelmüller H
Arzneimittelforschung; 1983; 33(9):1230-1. PubMed ID: 6416260
[TBL] [Abstract][Full Text] [Related]
2. [Human i.v. immune globulin by chemical modification with beta-propiolactone/radiochemical study (author's transl)].
Stephan W; Fasold H
Arzneimittelforschung; 1980; 30(12):2090-3. PubMed ID: 7194066
[TBL] [Abstract][Full Text] [Related]
3. On the mutagenicity and immunogenicity of a beta-propiolactone-treated therapeutic IgG-preparation.
Pincus JH; Mortelmans K; Tanaka W; Stephan W; Lissner R
Arzneimittelforschung; 1981; 31(11):1924-8. PubMed ID: 6172136
[TBL] [Abstract][Full Text] [Related]
4. Placental transfer of class G immunoglobulins treated with beta-propiolactone (beta-PL) for intravenous application--a case report.
Höckel M; Kaufmann R
J Perinat Med; 1986; 14(3):205-8. PubMed ID: 3783391
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of hepatitis viruses and HIV in plasma and plasma derivatives by treatment with beta-propiolactone/UV irradiation.
Stephan W
Curr Stud Hematol Blood Transfus; 1989; (56):122-7. PubMed ID: 2642784
[TBL] [Abstract][Full Text] [Related]
6. [Inactivation of hepatitis non-A, non-B virus in intravenous immunoglobulins by beta-propiolactone].
Dichtelmüller H; Stephan W; Prince AM; Brotman B
Beitr Infusionsther; 1988; 21():202-4. PubMed ID: 2462976
[No Abstract] [Full Text] [Related]
7. [Beta-propiolactone for cold sterilization of heart valve transplants].
Wutzler P; Sprössig M; Wenzel KP; Mücke H
Z Exp Chir; 1975; 8(4):236-40. PubMed ID: 1053182
[TBL] [Abstract][Full Text] [Related]
8. [Chemical modification with beta-propiolactone as a general concept for the production of intravenously tolerable immunoglobulin preparations].
Stephan W
Beitr Infusionther Klin Ernahr; 1983; 11():20-5. PubMed ID: 6686024
[No Abstract] [Full Text] [Related]
9. Virus safety of beta-propiolactone treated plasma preparations. Clinical experiences.
Heinrich D; Sugg U; Brackmann HH; Stephan W; Lissner R
Dev Biol Stand; 1987; 67():311-7. PubMed ID: 3649316
[TBL] [Abstract][Full Text] [Related]
10. Differences among available immunoglobulin preparations for intravenous use.
Skvaril F; Gardi A
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S43-8. PubMed ID: 2456510
[TBL] [Abstract][Full Text] [Related]
11. A clinical study of the tolerance and safety of a beta-propiolactone-treated immunoglobulin.
Mondorf AW; Stephan W; Uthemann H; Schuppan D; Lissner R
Arzneimittelforschung; 1981; 31(11):1928-30. PubMed ID: 6797445
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of the Hutchinson strain of hepatitis non-A, non-B virus in intravenous immunoglobulin by beta-propiolactone.
Stephan W; Dichtelmüller H; Prince AM; Brotman B; Huima T
J Med Virol; 1988 Nov; 26(3):227-32. PubMed ID: 3144576
[TBL] [Abstract][Full Text] [Related]
13. Comparison of in vitro behaviour and in vivo efficacy of two 7S-immunoglobulin preparations for intravenous use.
Stephan W; Dichtelmüller H
Arzneimittelforschung; 1983; 33(11):1538-40. PubMed ID: 6686449
[TBL] [Abstract][Full Text] [Related]
14. [Principles of selective inactivation of the viral genome. III. Kinetics of the inactivation of bacteriophage MS2 infectivity by beta-propiolactone].
Budovskiĭ EI; Zalesskaia MA
Mol Biol (Mosk); 1985; 19(4):1139-47. PubMed ID: 4047036
[TBL] [Abstract][Full Text] [Related]
15. [Cultivation of mycoplasma in fluid media sterilized with beta-propiolactone].
Kiuntsel' V; Starost E; Meissner Kh
Vestn Akad Med Nauk SSSR; 1976; (5):60-2. PubMed ID: 969882
[No Abstract] [Full Text] [Related]
16. [Beta-propiolactone as a sterilizing agent in the preparation of homo- and heterologous bone transplants].
Savel'ev VI
Ortop Travmatol Protez; 1966 Apr; 27(4):53-6. PubMed ID: 4864694
[No Abstract] [Full Text] [Related]
17. Influence of hydroxylamine and beta-propiolactone on the kinetics of plaque growth of SP3 and SP8 phages of Bacillus subtilis.
Kaláb D
Acta Virol; 1968 Jul; 12(4):367-70. PubMed ID: 4386022
[No Abstract] [Full Text] [Related]
18. Undegraded human immunoglobulin for intravenous use.
Stephan W
Vox Sang; 1975; 28(6):422-37. PubMed ID: 807036
[TBL] [Abstract][Full Text] [Related]
19. Effect of beta-propiolactone in blood on routine haematological, biochemical, and serological investigations.
Freeman R; Codd AA; Selkon JB
Lancet; 1982 May; 1(8280):1048-9. PubMed ID: 6122856
[No Abstract] [Full Text] [Related]
20. Inactivation of hepatitis A virus added to pooled human plasma by beta-propiolactone treatment and ultraviolet irradiation.
Frösner GG; Stephan W; Dichtelmüller H
Eur J Clin Microbiol; 1983 Aug; 2(4):355-7. PubMed ID: 6313360
[No Abstract] [Full Text] [Related]
[Next] [New Search]
